Medicare Advantage (Part C) – MedPAC

An official website of the United States Government —

Here’s how you know

MedPAC > Our Work > Medicare Advantage (Part C)

Medicare Advantage (Part C)

Showing 1 - 10 out of 438

Apr 11, 2025 / Presentations

Exploring the effect of Medicare Advantage on rural hospitals

Research Areas:

Hospitals, Private Plans, Regional Issues

Apr 11, 2025 / Presentations

Assessing the utilization and delivery of Medicare supplemental benefits

Research Areas:

Beneficiaries and Coverage, Private Plans

Apr 11, 2025 / Presentations

Structural differences between the PDP and MA–PD markets

Research Areas:

Drugs, Devices, and Tests, Private Plans

Mar 13, 2025 / Reports

March 2025 Report to the Congress: Medicare Payment Policy

Research Areas:

Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Medicare Spending and Financing, Physicians And Other Health Professionals, Post-Acute Care, Private Plans

Mar 13, 2025 / Chapters

Executive summary (March 2025 Report)

Research Areas:

Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Medicare Spending and Financing, Physicians And Other Health Professionals, Post-Acute Care, Private Plans

Mar 13, 2025 / Chapters

Chapter 11: The Medicare Advantage program: Status report (March 2025 Report)

Research Areas:

Medicare Spending and Financing, Private Plans

Mar 07, 2025 / Transcripts

March 2025 public meeting transcript

Research Areas:

Beneficiaries and Coverage, Delivery System Reforms, Hospitals, Medicare Spending and Financing, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Regional Issues

Mar 07, 2025 / Presentations

Examining home health care use among Medicare Advantage enrollees

Research Areas:

Post-Acute Care, Private Plans

Feb 10, 2025 / Comment Letters

MedPAC comment on CMS’s advance notice of methodological changes for CY 2026 for Medicare Advantage capitation rates and Part C and D payment policies

Research Areas:

Drugs, Devices, and Tests, Medicare Spending and Financing, Private Plans

Jan 27, 2025 / Comment Letters

MedPAC comment on CMS’s proposed rule on policy and technical changes to the Medicare Advantage Program and Medicare Prescription Drug Benefit Program for 2026

Research Areas:

Drugs, Devices, and Tests, Medicare Spending and Financing, Private Plans